COMPASS Pathways to Participate in BTIG and Canaccord Genuity Investor Conferences
COMPASS Pathways to Participate in BTIG and Canaccord Genuity Investor ConferencesLondon, UK , Aug. 03, 2021 (GLOBE NEWSWIRE) -- COMPASS...
Year: 2021
Monopar Announces FDA Clearance to Proceed with Camsirubicin Clinical Trial Targeting Advanced Soft Tissue Sarcoma
WILMETTE, Ill., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on...
Arbutus to Present at Wedbush PacGrow Healthcare Virtual Conference
WARMINSTER, Pa., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on...
Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021
NEWARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc., (NasdaqGS: RAIN) a late-stage company developing precision oncology therapeutics,...
Cue Biopharma to Present Corporate Update at the Upcoming BTIG Virtual Biotechnology Conference
CAMBRIDGE, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel...
Assembly Bio Announces Key Promotions to Leadership Team
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing...
Kiniksa Reports Second Quarter 2021 Financial Results and Recent Corporate and Portfolio Activity
- Q2 2021 ARCALYST® (rilonacept) net revenue of $7.7 million with greater than 100 prescribing physicians - - Phase 3...
aTyr Pharma to Webcast Conference Call Reporting Second Quarter 2021 Financial Results
Management to host conference call and webcast on August 10th at 5:00 pm EDT / 2:00 pm PDTSAN DIEGO, Aug....
Pliant Therapeutics to Participate in the BTIG Biotechnology Conference
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company...
Lumos Pharma Announces Industry Veteran, David B. Karpf, MD, has Joined the Company as Chief Medical Officer
AUSTIN, Texas, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for...
HTG Molecular Diagnostics to Announce Second Quarter 2021 Financial Results and Host Conference Call on Thursday, August 12
TUCSON, Ariz., Aug. 03, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission...
Pacific Biosciences Acquires Circulomics – A Leading High Molecular Weight DNA Extraction Company
Technology Will Enable Continued End-to-End Automated Workflow DevelopmentMENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California,...
Mindset Files International Patent Application for its Novel Psilocybin Synthesis Method
TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE:MSET) (FSE:9DF) (OTCQB:MSSTF) (“Mindset” or the “Company”), a drug discovery...
Alignment Healthcare Nearly Doubles Geographic Footprint, Expanding into 16 New Markets to Reach 6.9 Million Medicare Enrollees in 2022
ORANGE, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Since its debut as a public company earlier this year, award-winning Medicare...
X4 Pharmaceuticals Announces Key Enrollment Milestone Achievements in Ongoing Mavorixafor Clinical Trials and Reports Second Quarter Financial Results
Twenty-three patients now enrolled in ongoing pivotal Phase 3 trial in WHIM syndrome, surpassing minimum needed for primary endpoint analyses;...
Complete Response Letter Received from FDA for Treosulfan
TORONTO and CHICAGO and WEDEL, Germany, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX:...
Tauriga Sciences Inc. Confirms That It’s on Pace for a Strong Quarter From Its Retail Business
The Company’s Current Operating Quarter is Its 2nd Fiscal Quarter 2022 (Period: July 1, 2021 – September 30, 2021) NEW YORK,...
Acerus to Report Q2-2021 Financial Results and Host Investor Call
TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its second quarter 2021 financial and...
OpGen Achieves Key Development Milestone in Unyvero A30 RQ Platform Program
- OpGen subsidiary Curetis and its instrument development partner have completed assembly of 10 final pre-series release A30 RQ analyzers...
Matinas BioPharma to Participate in BTIG Virtual Biotechnology Conference
BEDMINSTER, N.J., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that Jerome D....